ProfileGDS4095 / 216114_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 43% 39% 40% 41% 44% 44% 42% 45% 44% 42% 45% 45% 44% 45% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.9245843
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.70539
GSM709765LY2 SRC1-siRNA untreated rep32.788140
GSM709771LY2 SRC1-siRNA untreated rep12.7946641
GSM709772LY2 SRC1-siRNA untreated rep22.9916144
GSM709775LY2 SRC1-siRNA untreated rep42.9686444
GSM709764LY2 control-siRNA tamoxifen treated rep22.8952642
GSM709766LY2 control-siRNA tamoxifen treated rep33.0895945
GSM709768LY2 control-siRNA tamoxifen treated rep12.9807144
GSM709777LY2 control-siRNA tamoxifen treated rep42.909642
GSM709770LY2 control-siRNA untreated rep33.0706745
GSM709773LY2 control-siRNA untreated rep13.0363245
GSM709774LY2 control-siRNA untreated rep22.9874744
GSM709776LY2 control-siRNA untreated rep43.0422645